US Stocks
/
Edgewise Therapeutics, Inc. Share Price
Edgewise Therapeutics, Inc. Share Price

Edgewise Therapeutics, Inc. Share Price

NASDAQ: EWTX | Mid Cap
$39.02
-$0.32 (-0.83%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Edgewise Therapeutics, Inc. Stock Performance

Open
$39.50
Prev. Close
$39.34
Circuit Range
N/A
Day Range
$38.96 - $40.23
Year Range
$14.26 - $48.50
Volume
55,413
Average Traded
$39.29

Edgewise Therapeutics, Inc. Share Price Today

As of 10 October 2026, Edgewise Therapeutics, Inc.'s share price is $39.02. The stock opened at $39.50, compared to its previous close of $39.34. During today's trading session, Edgewise Therapeutics, Inc.'s share price traded between $38.96 and $40.23, with an average price of $39.59. Over the past 52 weeks, the stock has recorded a high of $48.50 and a low of $14.26. In terms of performance, Edgewise Therapeutics, Inc.'s share price has risen by 26.03% over the last six months and is up 113.22% on a year-on-year basis.

Edgewise Therapeutics, Inc. Share Price Chart

$38.96$40.23
L
Show Current Price
H

Edgewise Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.02B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.82
Revenue (TTM)
$0.00
Return On Equity (TTM)
-44.02%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-40.96%

Edgewise Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$40.67-$50.22-$49.01-$57.33
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-23.48%2.41%-16.98%

Edgewise Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$67.64-$100.16-$133.81-$167.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-48.08%-33.60%-25.40%

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Edgewise Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$40.88
$39.09
-3.98%
Sep 2026
$41.82
$40.71
-7.98%
Aug 2026
$38.48
$44.24
+15.12%
Jul 2026
$40.97
$38.43
-5.41%
Jun 2026
$40.53
$40.63
+18.96%
May 2026
$30.80
$34.16
+10.32%
Apr 2026
$32.63
$30.96
-1.68%
Mar 2026
$30.07
$31.49
+3.47%
Feb 2026
$28.13
$30.43
+8.10%
Jan 2026
$25.08
$28.16
+13.51%
Dec 2025
$26.08
$24.80
-4.85%
Nov 2025
$18.38
$26.07
+42.46%

EWTX Share Price FAQs

What is Edgewise Therapeutics, Inc. share price today?

chevron-up
Edgewise Therapeutics, Inc. share price today is $39.02 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Edgewise Therapeutics, Inc. stock?

chevron-up
The 52 week high of Edgewise Therapeutics, Inc. stock is $48.50, while the 52 week low is $14.26 as of 10 Oct '26.

What is EWTX's market capitalisation today?

chevron-up
EWTX market capitalisation is $4.02B as of October 10, 2026, at 5:19 am IST.

What is EWTX's net income for the last quarter?

chevron-up
EWTX's net income for the last quarter is -57.33B USD.

What is the 5 year returns of EWTX?

chevron-up
The 5 year returns of EWTX is 136.48% as on 10 Oct '26.

What is the high & low stock price of EWTX today?

chevron-up
EWTX stock price hit a high of $40.23 and low of $38.96 as of 10 Oct '26.

Can I buy EWTX shares in India?

chevron-up
Yes. You can buy EWTX in India by opening an international trading account.